ResearcherThe University of Texas Southwestern Medical CenterNo recent work listed
Jorge Franco
Matched on OpenAlex author ID A5109920465. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2014: 1 paper · 2015: 1 paper · 2016: 1 paper
Papers 3
- Metabolic Reprogramming of Pancreatic Cancer Mediated by CDK4/6 Inhibition Elicits Unique Vulnerabilities. Co-author DOI 10.1016/j.celrep.2015.12.094↗
- Selective impact of CDK4/6 suppression on patient-derived models of pancreatic cancer. Co-author DOI 10.18632/oncotarget.3819↗
- CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer. Co-author DOI 10.18632/oncotarget.2270↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Erik S. Knudsen · 3 shared papers, 2014–2016 · strength 0.20
- Paper Metabolic Reprogramming of Pancreatic Cancer Mediated by CDK4/6 Inhibition Elicits Unique Vulnerabilities. DOI 10.1016/j.celrep.2015.12.094↗
- Paper CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic… DOI 10.18632/oncotarget.2270↗
- Paper Selective impact of CDK4/6 suppression on patient-derived models of pancreatic cancer. DOI 10.18632/oncotarget.3819↗
- Agnieszka Katarzyna Witkiewicz · 3 shared papers, 2014–2016 · strength 0.20
- Paper Metabolic Reprogramming of Pancreatic Cancer Mediated by CDK4/6 Inhibition Elicits Unique Vulnerabilities. DOI 10.1016/j.celrep.2015.12.094↗
- Paper CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic… DOI 10.18632/oncotarget.2270↗
- Paper Selective impact of CDK4/6 suppression on patient-derived models of pancreatic cancer. DOI 10.18632/oncotarget.3819↗
- Jonathan Robert Brody · 1 shared paper, 2015 · strength 0.05
- Charles J. Yeo · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.